Diuretics, often called “water pills,” remain a first-line treatment for hypertension — effective, inexpensive, and backed by decades of evidence. This guide breaks down the three main classes, how they lower blood pressure, potential side effects, and what the latest 2025–2026 guidelines say about their use.
Diuretics lower blood pressure by helping the kidneys excrete excess sodium and water, reducing blood volume. Thiazide diuretics (e.g., chlorthalidone, hydrochlorothiazide) are the most commonly prescribed type for hypertension and are recommended as monotherapy or combination therapy by the 2025 AHA/ACC guidelines. Loop diuretics are reserved for patients with heart failure or kidney impairment, while potassium-sparing diuretics are often added to counteract electrolyte losses.
What Are Diuretics, Exactly?
Diuretics are a class of medications that increase the output of urine (diuresis). By doing so, they reduce the volume of fluid circulating in your blood vessels, which directly lowers blood pressure. The concept is simple, but the clinical nuance matters: not all diuretics work the same way, and the wrong choice can lead to electrolyte disturbances or kidney stress.
In the U.S., nearly 120 million adults have hypertension, and diuretics have been a cornerstone of treatment for more than 60 years[1]. Their low cost, once-daily dosing, and proven ability to reduce cardiovascular events — especially strokes — make them a frequent first pick, particularly in Black patients and older adults.
How Diuretics Lower Blood Pressure
All diuretics act on the kidneys, but they target different segments of the nephron (the kidney’s filtering unit). The shared end result is a decrease in total body sodium and water, which reduces the volume of blood the heart has to pump. This reduction in preload and, in some cases, afterload, brings pressure down.
Thiazide diuretics, for example, block the sodium‑chloride cotransporter in the distal convoluted tubule. Initially, they cause a brisk diuresis, but over weeks, the main antihypertensive effect shifts to a reduction in peripheral vascular resistance — meaning the blood vessels themselves relax[2]. Loop diuretics act on the thick ascending limb of the loop of Henle, producing a much more powerful diuresis, which is why they’re used in fluid overload states (heart failure, renal failure) rather than uncomplicated hypertension.
Types of Diuretics Used for Hypertension
There are three main categories, each with distinct indications and risk profiles.
| Class | Examples | Typical Dose (hypertension) | Key Characteristics |
|---|---|---|---|
| Thiazide / Thiazide‑like | Hydrochlorothiazide (HCTZ), Chlorthalidone, Indapamide | 12.5–50 mg once daily | Preferred first‑line; longer half‑life chlorthalidone may be superior for CV events |
| Loop | Furosemide, Bumetanide, Torsemide | 20–80 mg once or twice daily (not typical for isolated hypertension) | Reserved for CKD (eGFR <30), heart failure, severe edema |
| Potassium‑sparing | Spironolactone, Eplerenone, Amiloride | 25–100 mg once daily (spironolactone) | Often added to thiazides to offset potassium loss; aldosterone antagonists reduce mortality in HF |
Thiazide diuretics remain the guideline‑preferred option for most people with hypertension. The 2025 AHA/ACC guideline recommends chlorthalidone or indapamide over HCTZ due to superior outcome data in major trials[3].
Efficacy and Guideline Recommendations
The Antihypertensive and Lipid‑Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) — one of the largest hypertension trials ever conducted — found that chlorthalidone was at least as effective as a calcium channel blocker (amlodipine) and an ACE inhibitor (lisinopril) in preventing fatal coronary heart disease and nonfatal MI, and it was superior for preventing heart failure[4].
Current U.S. guidelines (AHA/ACC, 2025) list thiazide diuretics as one of the four first‑line drug classes for stage 1 hypertension (≥130/80 mmHg) and recommend combination therapy — often an ACE inhibitor or ARB with a thiazide — for stage 2 hypertension (≥140/90 mmHg)[3]. International guidance from the International Society of Hypertension echoes this approach.
For Black patients, the AHA/ACC guideline specifically recommends a thiazide or a calcium channel blocker as initial therapy, because ACE inhibitors and ARBs tend to be less effective in this population due to differences in the renin‑angiotensin system.
Side Effects and Precautions
Diuretics are generally well tolerated, but they can cause electrolyte abnormalities — especially hypokalemia (low potassium) and hyponatremia (low sodium) — as well as increased uric acid levels, which may trigger gout in predisposed individuals.
- Hypokalemia — muscle cramps, weakness, palpitations (more common with loop and thiazide diuretics)
- Hyperuricemia / Gout — joint pain, especially in the big toe
- Volume depletion — dizziness, lightheadedness, especially when standing up
- Hyperglycemia — thiazides can slightly raise blood glucose; relevant for patients with diabetes
- Sexual dysfunction — less common but reported, particularly with high doses of thiazides
Routine monitoring of serum electrolytes, renal function (creatinine, eGFR), and blood glucose is standard. The American Diabetes Association recommends checking a basic metabolic panel within 2–4 weeks of starting a diuretic and at least annually thereafter[5].
Drug Interactions and When to Speak Up
Diuretics interact with several common medications:
- NSAIDs (ibuprofen, naproxen, celecoxib) — can reduce the antihypertensive effect and increase the risk of kidney injury.
- Lithium — diuretics can raise lithium levels, leading to toxicity.
- Digoxin — hypokalemia from diuretics increases the risk of digoxin toxicity.
- Other antihypertensives — additive blood‑pressure‑lowering effects; dose adjustments may be needed.
Always bring a current medication list to every appointment, including over‑the‑counter products and supplements.
Who Should Avoid Diuretics?
Diuretics are not appropriate for everyone. People with severely impaired kidney function (eGFR <30 mL/min/1.73 m²) typically require loop diuretics instead of thiazides. Those with a history of gout — particularly acute attacks — should use thiazides cautiously, as they can raise uric acid levels. Potassium‑sparing diuretics are contraindicated in patients with hyperkalemia (potassium >5.0 mEq/L) or advanced kidney disease.
Pregnant women with hypertension should generally avoid diuretics because they can reduce placental perfusion; methyldopa, labetalol, or nifedipine are preferred in pregnancy.
Frequently Asked Questions
Can I take a diuretic if I already have low potassium?
It depends. If your potassium is low, a thiazide or loop diuretic will lower it further, increasing the risk of arrhythmias. Your doctor may choose a potassium‑sparing diuretic (e.g., spironolactone) or add a potassium supplement. Always check potassium levels before starting a diuretic.
How long does it take for a diuretic to lower blood pressure?
You may notice a slight drop within the first few hours due to volume loss, but the full antihypertensive effect typically takes 2–4 weeks. The gradual reduction in vascular resistance accounts for the delayed response.
Do I need to restrict salt while taking a diuretic?
Yes — limiting sodium intake (ideally <2,300 mg/day, and <1,500 mg/day for those with hypertension) helps the diuretic work more effectively and reduces the risk of hypokalemia. The DASH diet remains the gold‑standard eating pattern alongside diuretic therapy.
Can I stop taking my diuretic once my blood pressure is normal?
Not without your doctor’s guidance. Hypertension is a chronic condition; stopping medication often causes blood pressure to rise again, sometimes to dangerous levels. If you’ve made significant lifestyle changes — weight loss, consistent exercise, dietary sodium reduction — your doctor may gradually reduce or discontinue the diuretic, but this should always be done under medical supervision.
- Thiazide diuretics (especially chlorthalidone) are first‑line agents for most adults with hypertension, as recommended by the 2025 AHA/ACC guidelines.
- Diuretics work by reducing blood volume and, over time, lowering peripheral vascular resistance — a dual mechanism that delivers durable blood pressure control.
- Electrolyte monitoring (potassium, sodium) and renal function tests are essential when starting or adjusting therapy.
- Loop diuretics are reserved for patients with heart failure or advanced kidney disease; potassium‑sparing diuretics are often added to counteract hypokalemia.
- Drug interactions (NSAIDs, lithium, digoxin) and contraindications (gout, hyperkalemia, pregnancy) should be reviewed before prescribing.
- Centers for Disease Control and Prevention. Hypertension Prevalence, Awareness, Treatment, and Control Among Adults — United States, 2017–2020. MMWR 2022;71(29):909–914.
- Ellison DH, Loffing J. Thiazide diuretics: molecular mechanisms, clinical applications, and emerging targets. Annu Rev Med 2021;72:241–257.
- Whelton PK, Carey RM, Mancia G, et al. 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol 2025;85(11):1234–1298.
- ALLHAT Officers and Coordinators. Major outcomes in high‑risk hypertensive patients randomized to angiotensin‑converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002;288(23):2981–2997.
- American Diabetes Association. Standards of Care in Diabetes — 2026. Diabetes Care 2026;49(Suppl 1):S1–S224.
